Chief Executive Officer & Founder & Chairman

OX40 Targeted Therapy Clinical Trials Anti OX40 Antibody Development Market Opportunity Insight 2026

Hedge Funds Sit Out IPO Revival Despite Billion-Dollar Quarter

Inmagene Biopharmaceuticals Announces Completion of Merger with Ikena Oncology and Concurrent Private Placement of $75 Million

iKena Oncology appoints Yarema as CEO of ImageneBio

Director of Quality Assurance

ImageneBio is a global clinical-stage biotechnology company focused on developing novel therapeutics for immunological and inflammatory diseases. They are seeking a Director of Quality Assurance to ensure quality, compliance, and safety throughout product development, manufacture, and commercialization, while maintaining high quality standards in accordance with current Good Manufacturing Practice (cGMP).

Sign up with Google

Sign in with Google